Grace Therapeutics, Inc. Share Price
NASDAQ: GRCE | Micro CapGrace Therapeutics, Inc. Stock Performance
Open $2.13 | Prev. Close $2.14 | Circuit Range N/A |
Day Range $2.10 - $2.15 | Year Range $1.79 - $5.15 | Volume 1,865 |
Average Traded $2.13 |
Grace Therapeutics, Inc. Share Price Today
As of 9 August 2026, Grace Therapeutics, Inc.'s share price is $2.10. The stock opened at $2.13, compared to its previous close of $2.14. During today's trading session, Grace Therapeutics, Inc.'s share price traded between $2.10 and $2.15, with an average price of $2.13. Over the past 52 weeks, the stock has recorded a high of $5.15 and a low of $1.79. In terms of performance, Grace Therapeutics, Inc.'s share price has declined by 51.16% over the last six months and is down 29.77% on a year-on-year basis.
Grace Therapeutics, Inc. Share Price Chart
Grace Therapeutics, Inc. Stock Fundamentals & Key Indicators
Market Cap $25.38M | PE Ratio (TTM) -2.66 | Dividend Yield N/A |
EPS (TTM) $-0.79 | Revenue (TTM) N/A | Return On Equity (TTM) -14.36% |
Profit Margin N/A | Debt to Equity 0.03 | Quarterly Earnings Growth YoY 11.54% |
Grace Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Grace Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Grace Therapeutics, Inc.
Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an intravenous infusion to treat subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal spray of betamethasone to improve neurological symptoms of Ataxia-Telangiectasia (A-T) and GTX-101, a topical bioadhesive film-forming polymer for the treatment of pain associated with postherpetic neuralgia (PHN). The company was formerly known as Acasti Pharma Inc. and changed its name to Grace Therapeutics, Inc. in October 2024. Grace Therapeutics, Inc. was incorporated in 2002 and is headquartered in Princeton, New Jersey.
Grace Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $2.13 | $2.10 | +0.48% |
Jul 2026 | $2.32 | $2.09 | -7.93% |
Jun 2026 | $2.60 | $2.27 | -12.36% |
May 2026 | $2.30 | $2.59 | +14.60% |
Apr 2026 | $4.78 | $2.26 | -51.29% |
Mar 2026 | $4.19 | $4.64 | +7.91% |
Feb 2026 | $3.69 | $4.30 | +17.49% |
Jan 2026 | $3.51 | $3.66 | +4.57% |
Dec 2025 | $3.19 | $3.50 | +10.06% |
Nov 2025 | $3.14 | $3.18 | +0.00% |
Oct 2025 | $3.00 | $3.18 | +8.53% |
Sep 2025 | $2.99 | $2.93 | -2.01% |
GRCE Share Price FAQs
What is Grace Therapeutics, Inc. share price today?
What is the 52 week high and 52 week low of Grace Therapeutics, Inc. stock?
What is GRCE's market capitalisation today?
What is GRCE's net income for the last quarter?
What is the 5 year returns of GRCE?
What is the high & low stock price of GRCE today?
Can I buy GRCE shares in India?